IL274795A - Increasing telomere length in a cell - Google Patents

Increasing telomere length in a cell

Info

Publication number
IL274795A
IL274795A IL274795A IL27479520A IL274795A IL 274795 A IL274795 A IL 274795A IL 274795 A IL274795 A IL 274795A IL 27479520 A IL27479520 A IL 27479520A IL 274795 A IL274795 A IL 274795A
Authority
IL
Israel
Prior art keywords
cell
telomere length
increasing telomere
increasing
length
Prior art date
Application number
IL274795A
Other languages
Hebrew (he)
Other versions
IL274795B1 (en
IL274795B2 (en
Original Assignee
Optigenex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Optigenex Inc filed Critical Optigenex Inc
Publication of IL274795A publication Critical patent/IL274795A/en
Publication of IL274795B1 publication Critical patent/IL274795B1/en
Publication of IL274795B2 publication Critical patent/IL274795B2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/74—Rubiaceae (Madder family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Battery Electrode And Active Subsutance (AREA)
IL274795A 2017-11-30 2018-11-21 Increasing telomere length in a cell IL274795B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15/827,223 US10098922B1 (en) 2017-11-30 2017-11-30 Increasing telomere length in a cell
PCT/US2018/062201 WO2019108454A1 (en) 2017-11-30 2018-11-21 Increasing telomere length in a cell

Publications (3)

Publication Number Publication Date
IL274795A true IL274795A (en) 2020-07-30
IL274795B1 IL274795B1 (en) 2023-08-01
IL274795B2 IL274795B2 (en) 2023-12-01

Family

ID=63762077

Family Applications (1)

Application Number Title Priority Date Filing Date
IL274795A IL274795B2 (en) 2017-11-30 2018-11-21 Increasing telomere length in a cell

Country Status (13)

Country Link
US (1) US10098922B1 (en)
EP (1) EP3492093A1 (en)
JP (1) JP2019099562A (en)
KR (1) KR20200095495A (en)
CN (1) CN109847071B (en)
BR (1) BR102018074717A8 (en)
CA (1) CA3021111A1 (en)
IL (1) IL274795B2 (en)
MX (1) MX2018014226A (en)
MY (1) MY194907A (en)
RU (1) RU2714886C1 (en)
TR (1) TR201817009A2 (en)
WO (1) WO2019108454A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10098922B1 (en) * 2017-11-30 2018-10-16 Optigenex, Inc. Increasing telomere length in a cell
US11883457B1 (en) * 2022-09-06 2024-01-30 Optigenex Inc. Method of enhancing cognition in individuals with at least normal cognition

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5385938B1 (en) 1986-12-23 1997-07-15 Tristrata Inc Method of using glycolic acid for treating wrinkles
US5489508A (en) 1992-05-13 1996-02-06 University Of Texas System Board Of Regents Therapy and diagnosis of conditions related to telomere length and/or telomerase activity
US5741677A (en) 1995-06-07 1998-04-21 Geron Corporation Methods for measuring telomere length
US6039949A (en) * 1997-02-27 2000-03-21 Campamed, Inc. Method of preparation and composition of a water soluble extract of the plant species uncaria
CA2289531C (en) * 1997-05-15 2009-09-29 University Of Washington Composition and methods for treating alzheimer's disease and other amyloidoses
EP1335738A4 (en) * 2000-11-03 2004-09-08 Proteotech Inc Methods of isolating amyloid-inhibiting compounds and use of compounds isolated from uncaria tomentosa and related plants
US6964784B2 (en) * 2002-03-07 2005-11-15 Optigenex, Inc. Method of preparation and composition of a water soluble extract of the bioactive component of the plant species uncaria for enhancing immune, anti-inflammatory, anti-tumor and dna repair processes of warm blooded animals
BRPI0411856A (en) 2003-06-23 2006-08-29 Geron Corp compositions and methods for increasing telomerase activity
RU2007138220A (en) * 2005-03-16 2009-04-27 Рональд В. ПЕРО (SE) MEDICAL COMPOSITIONS OF SALTS, CHELATES AND / OR FREE ACIDS, ORGANIC ACIDS WITH ALPHA HYDROXYL AND RELATED PROCESSES AND METHODS
US8372488B2 (en) * 2006-05-01 2013-02-12 General Electric Company Methods and apparatus for thermal barrier coatings with improved overall thermal insulation characteristics
CA2690004C (en) * 2007-06-04 2018-01-23 Ben-Gurion University Of The Negev Research And Development Authority Tri-aryl compounds and compositions comprising the same
US8029830B2 (en) * 2008-04-18 2011-10-04 Nuvocare Health Services Inc. Composition and method for promoting internal health and external appearance
WO2010065567A2 (en) * 2008-12-01 2010-06-10 Lifespan Extension Llc Methods and compositions for altering health, wellbeing, and lifespan
ES2656958T3 (en) * 2011-03-28 2018-03-01 Geron Corporation Measurement of telomere length in samples fixed in formalin, embedded in paraffin (FFPE) by quantitative PCR
US8747915B1 (en) * 2011-09-14 2014-06-10 Vincent C. Giampapa Dietary supplement system for multifunctional anti-aging management and method of use
US9345733B1 (en) * 2011-09-14 2016-05-24 Cellhealth Technologies Ltd. Supplement composition for supporting telomere maintenance and protection and method of use
US8968801B1 (en) * 2011-09-14 2015-03-03 Cellhealth Technologies Ltd. Supplement composition for supporting DNA repair and method of use
EP2934558A4 (en) * 2012-12-21 2016-07-27 Joel R L Ehrenkranz Supplements and monitoring systems for dosing of the supplements
WO2014153356A1 (en) * 2013-03-18 2014-09-25 Life Science Institute, Llc An in vivo intracellular reprogramming composition and method of making and using same
US9968546B2 (en) 2015-11-10 2018-05-15 Vincent C Giampapa Topical composition for skin treatment to reduce lines and wrinkles of the face and body using a dual DNA repair mechanism to address damage caused by aging and ultra-violet induced damage to the skin with combination of skin turgor enhancement compounds
US10098922B1 (en) * 2017-11-30 2018-10-16 Optigenex, Inc. Increasing telomere length in a cell

Also Published As

Publication number Publication date
WO2019108454A1 (en) 2019-06-06
KR20200095495A (en) 2020-08-10
CN109847071A (en) 2019-06-07
TR201817009A2 (en) 2019-06-21
IL274795B1 (en) 2023-08-01
US10098922B1 (en) 2018-10-16
IL274795B2 (en) 2023-12-01
MY194907A (en) 2022-12-22
BR102018074717A2 (en) 2019-06-25
BR102018074717A8 (en) 2023-03-07
JP2019099562A (en) 2019-06-24
EP3492093A1 (en) 2019-06-05
CN109847071B (en) 2022-07-19
RU2714886C1 (en) 2020-02-20
MX2018014226A (en) 2019-10-14
CA3021111A1 (en) 2019-05-30

Similar Documents

Publication Publication Date Title
GB201621889D0 (en) Cell
GB201813178D0 (en) Cell
GB201610515D0 (en) Cell
IL273915A (en) Cell
AP01012S1 (en) Battery
GB201714718D0 (en) Cell
GB201707783D0 (en) Cell
GB201707779D0 (en) Cell
GB201603372D0 (en) Cell
GB201803079D0 (en) Cell
GB201720949D0 (en) Cell
ZA201900891B (en) B-cell-mimetic cells
GB201718697D0 (en) Cell
GB201509040D0 (en) Cell lines
IL274795A (en) Increasing telomere length in a cell
GB201609604D0 (en) Cell
GB201617716D0 (en) Cell
GB201807693D0 (en) Cell
GB201711384D0 (en) A stress cell
GB2555033B (en) A lithium-sulphur cell
GB201816399D0 (en) Cell
GB201814663D0 (en) Improvements in manufacturing
GB201805918D0 (en) Cell
PL3444868T3 (en) Battery cell
GB201717713D0 (en) Battery